Coming soon: CAR T-cell approvals in multiple myelomaApril 26, 2018Leukemia, Myelodysplasia, Transplantation
World Trade Center responders face greater cancer burden, including greater risk of multiple myelomaApril 26, 2018Leukemia, Myelodysplasia, TransplantationPatient & Survivor CarePreventive CareGenitourinary CancerMelanoma
Checkpoint inhibition after HiDAC shows promise in AMLApril 18, 2018Leukemia, Myelodysplasia, Transplantation
Venetoclax shows muscle against CLL relapsed after idelalisibApril 18, 2018Leukemia, Myelodysplasia, Transplantation
Ibrutinib plus carfilzomib active in relapsed multiple myelomaApril 18, 2018Leukemia, Myelodysplasia, Transplantation
5- and 10-day decitabine go head-to-head in poor-risk AMLApril 18, 2018Leukemia, Myelodysplasia, Transplantation
Statin plus chemo yields encouraging results in poor-risk AMLApril 17, 2018Leukemia, Myelodysplasia, Transplantation
Blinatumomab triggers complete MRD response in ALLApril 12, 2018Leukemia, Myelodysplasia, TransplantationImmuno-oncology
Do industry payments increase prescribing for some targeted therapies?April 9, 2018Practice ManagementRenal Cell CarcinomaLeukemia, Myelodysplasia, Transplantation
Age and race affect access to myeloma treatmentApril 6, 2018Leukemia, Myelodysplasia, Transplantation
Updated CLL guidelines incorporate a decade of advancesApril 6, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
European Commission expands denosumab indicationApril 4, 2018Leukemia, Myelodysplasia, Transplantation
